CN Stock MarketDetailed Quotes

000999 China Resources Sanjiu Medical & Pharmaceutical

Watchlist
  • 40.31
  • -0.28-0.69%
Not Open Jul 30 15:00 CST
51.78BMarket Cap16.89P/E (TTM)

China Resources Sanjiu Medical & Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
14.82%7.29B
36.83%24.74B
53.65%18.61B
56.48%13.15B
49.46%6.35B
16.31%18.08B
7.53%12.11B
6.82%8.4B
4.18%4.25B
13.98%15.54B
Operating revenue
14.82%7.29B
36.83%24.74B
53.65%18.61B
56.48%13.15B
49.46%6.35B
16.31%18.08B
7.53%12.11B
6.82%8.4B
4.18%4.25B
13.98%15.54B
Other operating revenue
----
34.95%901.47M
----
51.43%553.78M
----
-7.14%667.99M
----
5.24%365.69M
----
32.16%719.33M
Total operating cost
13.81%5.49B
37.80%21.02B
57.00%15.41B
60.36%10.67B
48.74%4.82B
16.69%15.25B
6.66%9.81B
7.04%6.65B
-2.03%3.24B
12.27%13.07B
Operating cost
16.46%3.4B
39.14%11.57B
63.79%8.97B
65.75%6.28B
51.22%2.92B
30.83%8.31B
19.66%5.48B
19.71%3.79B
16.63%1.93B
24.11%6.35B
Operating tax surcharges
14.18%75.25M
32.77%274.91M
46.96%193.82M
50.55%135.89M
41.96%65.9M
1.27%207.06M
-0.21%131.88M
-3.98%90.27M
-6.70%46.42M
16.45%204.45M
Operating expense
11.26%1.56B
37.21%6.97B
48.90%4.77B
52.75%3.29B
43.32%1.4B
0.80%5.08B
-9.99%3.2B
-7.95%2.15B
-27.69%979.22M
0.42%5.04B
Administration expense
9.57%338.68M
43.92%1.52B
56.99%1.04B
55.50%677.45M
61.69%309.11M
10.81%1.06B
8.35%662.21M
6.53%435.65M
1.94%191.18M
2.57%955.35M
Financial expense
-223.79%-23.66M
-539.25%-24.19M
-91.99%-20.52M
59.86%-13.19M
17.82%-7.31M
114.57%5.51M
65.20%-10.69M
-7.17%-32.85M
35.46%-8.89M
33.88%-37.8M
-Interest expense (Financial expense)
114.47%20.82M
280.56%80.78M
266.28%52.29M
233.48%27.04M
162.78%9.71M
49.71%21.23M
52.77%14.28M
25.55%8.11M
63.57%3.69M
178.65%14.18M
-Interest Income (Financial expense)
-201.37%-46.12M
-45.43%-106.86M
-44.37%-72.75M
-7.36%-39.52M
-14.05%-15.3M
-9.32%-73.48M
4.12%-50.4M
10.03%-36.81M
21.18%-13.42M
8.84%-67.22M
Research and development
3.64%137.42M
20.30%714.5M
29.95%458.44M
37.30%295.21M
27.31%132.6M
6.02%593.94M
-0.65%352.79M
-8.99%215.01M
35.90%104.15M
21.82%560.2M
Credit Impairment Loss
-19.89%-38.23M
-1,034.45%-67.78M
-42.63%-42.68M
-117.53%-58.27M
-108.67%-31.89M
51.76%-5.97M
-86.39%-29.93M
-43.24%-26.79M
-207.57%-15.28M
47.05%-12.39M
Asset Impairment Loss
12.92%-20.54M
-24.85%-172.64M
-125.15%-78.07M
23.32%-17.9M
-20.57%-23.59M
46.09%-138.27M
44.66%-34.67M
-63.66%-23.34M
-74.93%-19.56M
-25.22%-256.48M
Other net revenue
45.51%-9.51M
-70.75%35.87M
-59.14%51.59M
-71.69%18.4M
-198.39%-17.46M
18,412.22%122.63M
29.46%126.25M
-32.07%64.98M
135.72%17.74M
-99.14%662.42K
Fair value change income
94.60%-321.82K
-1,209.83%-28.63M
-385.42%-6.6M
-153.74%-3.56M
---5.96M
-48.79%2.58M
-31.88%2.31M
142.89%6.62M
----
-26.64%5.04M
Invest income
-30.30%2.17M
-59.13%18.24M
-56.42%10.85M
-71.37%4.53M
5.47%3.11M
31.79%44.62M
48.18%24.9M
85.96%15.82M
-47.62%2.95M
-58.95%33.86M
-Including: Investment income associates
-235.42%-1.35M
-11.37%5.2M
1,057.82%5.23M
683.83%1.91M
384.54%995.83K
3,057.34%5.87M
-171.35%-545.76K
-62.23%244.09K
-68.13%205.52K
593.00%185.97K
Asset deal income
-10.05%843.5K
-64.28%813.69K
-16.34%2.68M
42.57%2.14M
-4.89%937.69K
167.98%2.28M
193.66%3.21M
1.31%1.5M
822.58%985.88K
131.65%850.16K
Other revenue
16.61%46.57M
31.50%285.87M
3.10%165.41M
0.32%91.45M
-17.91%39.94M
-5.39%217.39M
3.54%160.43M
-21.34%91.16M
167.53%48.65M
4.95%229.79M
Operating profit
18.76%1.8B
27.35%3.75B
34.20%3.25B
37.68%2.5B
47.46%1.51B
19.21%2.95B
12.27%2.42B
3.91%1.82B
31.82%1.03B
19.42%2.47B
Add:Non operating Income
194.43%11.82M
44.31%51.29M
39.27%27.2M
114.68%19.94M
57.01%4.01M
64.05%35.54M
76.73%19.53M
64.07%9.29M
-27.01%2.56M
30.09%21.67M
Less:Non operating expense
-18.56%6.56M
159.85%50.21M
99.31%27.77M
158.61%23.55M
95.84%8.06M
-61.33%19.32M
-64.87%13.93M
-26.75%9.1M
39.07%4.12M
82.25%49.97M
Total profit
19.43%1.8B
26.69%3.75B
33.86%3.25B
37.47%2.5B
47.29%1.51B
21.25%2.96B
14.04%2.43B
4.32%1.82B
31.53%1.03B
18.67%2.44B
Less:Income tax cost
24.82%349.98M
24.56%580.97M
23.38%554.54M
18.79%435.57M
59.76%280.39M
35.04%466.43M
28.57%449.47M
4.33%366.68M
33.36%175.51M
-21.83%345.41M
Net profit
18.20%1.45B
27.09%3.17B
36.24%2.7B
42.20%2.06B
44.71%1.23B
18.98%2.5B
11.18%1.98B
4.32%1.45B
31.16%849.6M
29.74%2.1B
Net profit from continuing operation
18.20%1.45B
27.09%3.17B
36.24%2.7B
42.20%2.06B
44.71%1.23B
18.98%2.5B
11.18%1.98B
4.32%1.45B
31.16%849.6M
29.74%2.1B
Less:Minority Profit
13.91%89.34M
564.91%320.55M
1,031.76%292.58M
1,076.61%182.73M
789.68%78.43M
10.85%48.21M
11.98%25.85M
21.24%15.53M
82.48%8.82M
117.02%43.49M
Net profit of parent company owners
18.49%1.36B
16.50%2.85B
23.06%2.4B
30.99%1.88B
36.90%1.15B
19.16%2.45B
11.17%1.95B
4.16%1.43B
30.77%840.79M
28.65%2.06B
Earning per share
Basic earning per share
19.83%1.39
16.94%2.9
22.61%2.44
30.82%1.91
34.88%1.16
18.10%2.48
11.17%1.99
3.55%1.46
30.30%0.86
28.83%2.1
Diluted earning per share
19.83%1.39
16.94%2.9
22.61%2.44
30.82%1.91
34.88%1.16
18.10%2.48
11.17%1.99
3.55%1.46
30.30%0.86
28.83%2.1
Other composite income
97.77%-96.17K
-107.40%-5.21M
-87.37%4.61M
1,703.99%7.23M
-6,656.29%-4.32M
1,273.94%70.39M
307.34%36.48M
-40.98%400.52K
-263.79%-63.88K
462.70%5.12M
Other composite income of parent company owners
99.49%-21.16K
-99.06%664.35K
-85.23%5.39M
1,593.27%6.78M
-6,356.30%-4.12M
1,259.34%70.38M
307.34%36.48M
-40.98%400.52K
-263.79%-63.88K
466.55%5.18M
Other composite income of minority owners
60.86%-75K
-67,478.48%-5.87M
---781.74K
--443.47K
---191.64K
116.03%8.72K
----
----
----
---54.36K
Total composite income
18.60%1.45B
23.40%3.17B
34.01%2.7B
42.66%2.07B
44.21%1.23B
22.04%2.57B
12.66%2.01B
4.30%1.45B
31.14%849.54M
30.17%2.1B
Total composite income of parent company owners
18.91%1.36B
13.27%2.85B
21.08%2.41B
31.42%1.88B
36.42%1.15B
22.27%2.52B
12.67%1.99B
4.14%1.43B
30.75%840.73M
29.08%2.06B
Total composite income of minority owners
14.10%89.27M
552.61%314.67M
1,028.73%291.8M
1,079.46%183.18M
787.51%78.24M
11.01%48.22M
11.98%25.85M
21.24%15.53M
82.48%8.82M
116.75%43.44M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 14.82%7.29B36.83%24.74B53.65%18.61B56.48%13.15B49.46%6.35B16.31%18.08B7.53%12.11B6.82%8.4B4.18%4.25B13.98%15.54B
Operating revenue 14.82%7.29B36.83%24.74B53.65%18.61B56.48%13.15B49.46%6.35B16.31%18.08B7.53%12.11B6.82%8.4B4.18%4.25B13.98%15.54B
Other operating revenue ----34.95%901.47M----51.43%553.78M-----7.14%667.99M----5.24%365.69M----32.16%719.33M
Total operating cost 13.81%5.49B37.80%21.02B57.00%15.41B60.36%10.67B48.74%4.82B16.69%15.25B6.66%9.81B7.04%6.65B-2.03%3.24B12.27%13.07B
Operating cost 16.46%3.4B39.14%11.57B63.79%8.97B65.75%6.28B51.22%2.92B30.83%8.31B19.66%5.48B19.71%3.79B16.63%1.93B24.11%6.35B
Operating tax surcharges 14.18%75.25M32.77%274.91M46.96%193.82M50.55%135.89M41.96%65.9M1.27%207.06M-0.21%131.88M-3.98%90.27M-6.70%46.42M16.45%204.45M
Operating expense 11.26%1.56B37.21%6.97B48.90%4.77B52.75%3.29B43.32%1.4B0.80%5.08B-9.99%3.2B-7.95%2.15B-27.69%979.22M0.42%5.04B
Administration expense 9.57%338.68M43.92%1.52B56.99%1.04B55.50%677.45M61.69%309.11M10.81%1.06B8.35%662.21M6.53%435.65M1.94%191.18M2.57%955.35M
Financial expense -223.79%-23.66M-539.25%-24.19M-91.99%-20.52M59.86%-13.19M17.82%-7.31M114.57%5.51M65.20%-10.69M-7.17%-32.85M35.46%-8.89M33.88%-37.8M
-Interest expense (Financial expense) 114.47%20.82M280.56%80.78M266.28%52.29M233.48%27.04M162.78%9.71M49.71%21.23M52.77%14.28M25.55%8.11M63.57%3.69M178.65%14.18M
-Interest Income (Financial expense) -201.37%-46.12M-45.43%-106.86M-44.37%-72.75M-7.36%-39.52M-14.05%-15.3M-9.32%-73.48M4.12%-50.4M10.03%-36.81M21.18%-13.42M8.84%-67.22M
Research and development 3.64%137.42M20.30%714.5M29.95%458.44M37.30%295.21M27.31%132.6M6.02%593.94M-0.65%352.79M-8.99%215.01M35.90%104.15M21.82%560.2M
Credit Impairment Loss -19.89%-38.23M-1,034.45%-67.78M-42.63%-42.68M-117.53%-58.27M-108.67%-31.89M51.76%-5.97M-86.39%-29.93M-43.24%-26.79M-207.57%-15.28M47.05%-12.39M
Asset Impairment Loss 12.92%-20.54M-24.85%-172.64M-125.15%-78.07M23.32%-17.9M-20.57%-23.59M46.09%-138.27M44.66%-34.67M-63.66%-23.34M-74.93%-19.56M-25.22%-256.48M
Other net revenue 45.51%-9.51M-70.75%35.87M-59.14%51.59M-71.69%18.4M-198.39%-17.46M18,412.22%122.63M29.46%126.25M-32.07%64.98M135.72%17.74M-99.14%662.42K
Fair value change income 94.60%-321.82K-1,209.83%-28.63M-385.42%-6.6M-153.74%-3.56M---5.96M-48.79%2.58M-31.88%2.31M142.89%6.62M-----26.64%5.04M
Invest income -30.30%2.17M-59.13%18.24M-56.42%10.85M-71.37%4.53M5.47%3.11M31.79%44.62M48.18%24.9M85.96%15.82M-47.62%2.95M-58.95%33.86M
-Including: Investment income associates -235.42%-1.35M-11.37%5.2M1,057.82%5.23M683.83%1.91M384.54%995.83K3,057.34%5.87M-171.35%-545.76K-62.23%244.09K-68.13%205.52K593.00%185.97K
Asset deal income -10.05%843.5K-64.28%813.69K-16.34%2.68M42.57%2.14M-4.89%937.69K167.98%2.28M193.66%3.21M1.31%1.5M822.58%985.88K131.65%850.16K
Other revenue 16.61%46.57M31.50%285.87M3.10%165.41M0.32%91.45M-17.91%39.94M-5.39%217.39M3.54%160.43M-21.34%91.16M167.53%48.65M4.95%229.79M
Operating profit 18.76%1.8B27.35%3.75B34.20%3.25B37.68%2.5B47.46%1.51B19.21%2.95B12.27%2.42B3.91%1.82B31.82%1.03B19.42%2.47B
Add:Non operating Income 194.43%11.82M44.31%51.29M39.27%27.2M114.68%19.94M57.01%4.01M64.05%35.54M76.73%19.53M64.07%9.29M-27.01%2.56M30.09%21.67M
Less:Non operating expense -18.56%6.56M159.85%50.21M99.31%27.77M158.61%23.55M95.84%8.06M-61.33%19.32M-64.87%13.93M-26.75%9.1M39.07%4.12M82.25%49.97M
Total profit 19.43%1.8B26.69%3.75B33.86%3.25B37.47%2.5B47.29%1.51B21.25%2.96B14.04%2.43B4.32%1.82B31.53%1.03B18.67%2.44B
Less:Income tax cost 24.82%349.98M24.56%580.97M23.38%554.54M18.79%435.57M59.76%280.39M35.04%466.43M28.57%449.47M4.33%366.68M33.36%175.51M-21.83%345.41M
Net profit 18.20%1.45B27.09%3.17B36.24%2.7B42.20%2.06B44.71%1.23B18.98%2.5B11.18%1.98B4.32%1.45B31.16%849.6M29.74%2.1B
Net profit from continuing operation 18.20%1.45B27.09%3.17B36.24%2.7B42.20%2.06B44.71%1.23B18.98%2.5B11.18%1.98B4.32%1.45B31.16%849.6M29.74%2.1B
Less:Minority Profit 13.91%89.34M564.91%320.55M1,031.76%292.58M1,076.61%182.73M789.68%78.43M10.85%48.21M11.98%25.85M21.24%15.53M82.48%8.82M117.02%43.49M
Net profit of parent company owners 18.49%1.36B16.50%2.85B23.06%2.4B30.99%1.88B36.90%1.15B19.16%2.45B11.17%1.95B4.16%1.43B30.77%840.79M28.65%2.06B
Earning per share
Basic earning per share 19.83%1.3916.94%2.922.61%2.4430.82%1.9134.88%1.1618.10%2.4811.17%1.993.55%1.4630.30%0.8628.83%2.1
Diluted earning per share 19.83%1.3916.94%2.922.61%2.4430.82%1.9134.88%1.1618.10%2.4811.17%1.993.55%1.4630.30%0.8628.83%2.1
Other composite income 97.77%-96.17K-107.40%-5.21M-87.37%4.61M1,703.99%7.23M-6,656.29%-4.32M1,273.94%70.39M307.34%36.48M-40.98%400.52K-263.79%-63.88K462.70%5.12M
Other composite income of parent company owners 99.49%-21.16K-99.06%664.35K-85.23%5.39M1,593.27%6.78M-6,356.30%-4.12M1,259.34%70.38M307.34%36.48M-40.98%400.52K-263.79%-63.88K466.55%5.18M
Other composite income of minority owners 60.86%-75K-67,478.48%-5.87M---781.74K--443.47K---191.64K116.03%8.72K---------------54.36K
Total composite income 18.60%1.45B23.40%3.17B34.01%2.7B42.66%2.07B44.21%1.23B22.04%2.57B12.66%2.01B4.30%1.45B31.14%849.54M30.17%2.1B
Total composite income of parent company owners 18.91%1.36B13.27%2.85B21.08%2.41B31.42%1.88B36.42%1.15B22.27%2.52B12.67%1.99B4.14%1.43B30.75%840.73M29.08%2.06B
Total composite income of minority owners 14.10%89.27M552.61%314.67M1,028.73%291.8M1,079.46%183.18M787.51%78.24M11.01%48.22M11.98%25.85M21.24%15.53M82.48%8.82M116.75%43.44M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg